Narrative identity, rationality, and microdosing classic psychedelics
Megan Webb, Heith Copes, Peter S. Hendricks
International Journal of Drug Policy May 8, 2019 DOI: 10.1016/j.drugpo.2019.04.013 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Qualitative study Peer reviewed |
|---|---|
| Sample size | 30 |
| Population | People who had microdosed classic psychedelics |
| Topics | Microdosing |
| Citations | 75 |
| Key findings | Microdosers framed their practice as rational and instrumental, emphasizing connections to conventional middle-class values to normalize their drug use. |
Abstract
BackgroundMicrodosing involves ingesting a small dose of a classic psychedelic (e.g., LSD and psilocybin) at regular intervals for prolonged periods. The practice is said to reduce anxiety, improve mood, and offer several creative and practical benefits to users. Using the narrative identity theoretical framework, our aim was to explore the experiences of those who microdosed classic psychedelics. Specifically, we sought to understand how and why they began microdosing and how they made sense of their actions in the context of their conventional lives.MethodsTo understand the experiences of those who microdose classic psychedelics, we rely on data collected from semi-structured interviews with 30 people who had microdosed.ResultsParticipants saw themselves as conventional citizens who microdosed for rational and instrumental purposes. They emphasized the rationality of microdosing by discussing (1) the practicality of their procurement and administration processes, (2) the connection between their microdosing practice and their general awareness in health and wellness, and (3) the benefits of the practice.ConclusionParticipants described their microdosing in the context of embracing traditional middle-class values. This created social distance between themselves and those who use drugs recreationally. While people who use drugs recreationally typically construct boundaries by distancing themselves from symbolic others (i.e., "crackheads," "meth heads," "junkies"), microdosers constructed boundaries by emphasizing connections to conventional citizens who embrace middle-class values. This connection to conventional citizens allows them to normalize their drug use and facilitates persistence.
Comparable studies
Other qualitative studies on microdosing, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Psychedelic microdosing benefits and challenges: an empirical codebook Active microdosing community | 2019 | Mixed-methods study | |
| Twenty percent better with 20 micrograms? A qualitative study of psychedelic microdosing self-rapports and discussions on YouTube YouTube videos and comments about psychedelic microdosing | 2019 | Qualitative study | |
| Accounting for Microdosing Classic Psychedelics People who had microdosed classic psychedelics | 2019 | Qualitative study | n = 30 |
| Experiences of microdosing psychedelics in an attempt to support wellbeing and mental health. People who microdose psychedelic drugs | 2023 | Qualitative study | n = 13 |
| Qualitative content analysis of expectations in participants with depression about to begin LSD microdosing treatment: Identifying the need for psychedelic expectancy measures. Individuals with major depressive disorder (MDD) | 2025 | Qualitative study | n = 23 |
Citations in the library
Cited by 59
- Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms Pharmacological Reviews December 16, 2020
- Making "bad trips" good: How users of psychedelics narratively transform challenging trips into valuable experiences. International Journal of Drug Policy 2021
- Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study Translational Psychiatry August 2, 2022
- Psychedelic Microdosing: A Subreddit Analysis Journal of Psychoactive Drugs October 24, 2019
- Microdosing psychedelics: Motivations, subjective effects and harm reduction International Journal of Drug Policy November 25, 2019
and 54 more in the library
Cites 12
- Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences Journal of Psychopharmacology August 31, 2016
- Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function. Pharmacology & Therapeutics May 1, 2019
- Exploring the effect of microdosing psychedelics on creativity in an open-label natural setting Psychopharmacology October 24, 2018
- Awe: a putative mechanism underlying the effects of classic psychedelic-assisted psychotherapy International Review of Psychiatry July 4, 2018
- Microdosing psychedelics: personality, mental health, and creativity differences in microdosers Psychopharmacology January 2, 2019
and 7 more in the library